ASC development + private equity: How to build value from day one

This webinar is on-demand and can be viewed at your convenience.

Private equity interest in ASCs remains strong, but long-term returns depend on how strategically each center is structured from the start.

In this on-demand webinar, senior healthcare advisors walk step-by-step through a development strategy designed to maximize value — covering everything from fair market value and compliance safeguards to M&A deal positioning.

Drawing on extensive ASC transaction experience, they share lessons to help organizations avoid costly missteps and ensure buyouts align with both clinical priorities and financial goals.

You'll gain insights on:

The development levers that elevate ASC enterprise value and drive lasting performance
How to strengthen compliance and valuation across FMV, diligence and documentation
Real-world deal structuring strategies, from buyer mix to rollover equity, that secure favorable terms

Presenters:

Andrew Hranka

Managing Director of M&A, Coker Group

Andrew Hranka, Managing Director of M&A, leads Coker’s sell-side practice and private equity relationships, with nearly 15 years of healthcare investment banking experience and more than $5B in executed transactions.

Wendy Bruno Thomson, MBA, LHA

Senior Vice President, Coker Group

Wendy Bruno Thomson, Senior Vice President, founded and leads TTG, a Coker company, where she focuses on financial and operational strategies to enhance the performance and value of practices and surgical facilities.

Richard Romero, CVA, ABV, FHFMA, PAHM

Senior Vice President, Coker Group

Richard Romero, Senior Vice President, oversees Coker’s healthcare valuation services, bringing more than 20 years of experience in FMV, regulatory compliance, and transaction advisory for hospitals, physician groups, and ASCs.